Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of QD202 injection in acute ischemic stroke patients receiving thrombolysis
CTR20253923Phase 2Active
- Sponsor
- Quatidi Biotech
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QD202 in ischemic stroke, sponsored by Quatidi Biotech. Started Nov 2025; status: active.
02
Drugs
QD202
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20253923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253923.